Evaluation of efficacy and safety of toothpastes against baseline and against each other in relief from hypersensitivity, improvement in the dental condition for toothache, dental caries and oral hygiene

Dabur India Limited0 个研究点目标入组 120 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects with age group 12-65 years in general good health and oral health.
•Subjects should have at least one tooth from which a painful response could be elicited by both a dental explorer and air blast.
•Subjects having ICADS score of less than 2 concerning dental caries.
•Subjects having extrinsic dental stains and bad oral hygiene.
•Subjects willing to give a voluntary written informed consent for photography release and agree to come for regular follow up.
•Subjects willing to abide by and comply with the study protocol.
•Subjects who have not participated in a similar investigation in the past four weeks.
•Subjects who will be available for the entire duration of the study.
•Subjects who are willing not to participate in any other clinical study during participation in the current study.

•A known history or present condition of hyper sensitivity to any tooth paste.
•The use of antibiotic, antimicrobial, analgesic medications, mouthwash or desensitizing toothpaste during the previous 1 month.
•Any history of periodontal therapy by surgical interventions.
•Any history of dentine hypersensitivity treatment.
•Orthodontic treatment with ï¬?xed appliances.
•Any removable device such as a removable partial denture or orthodontic retainer.
•The presence of any ï¬?xed appliance, large or defective restorations, cracked enamel, or caries on the History hypersensitive tooth.
•History of smoking or smokeless tobacco products.
•Subjects having intrinsic dental stains.
•Subjects having abnormal frenum attachment.
•Subjects who are pregnant, lactating or nursing.
•Subjects having severe level of calculus and/ tartar.
•Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.

发起方